Axon Enterprise, INC Form 4 insider transactions

Director Hadi Partovi reported transferring shares of Axon Enterprise, Inc. to his spouse on October 2nd and 7th, 2024.

Axon Enterprise's CEO, Patrick W. Smith, executed multiple sales of common stock on October 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise's CEO, Patrick W. Smith, engaged in multiple transactions involving the exercise of stock options and the sale of common stock, as part of a pre-arranged Rule 10b5-1 trading plan.

Director Jeri Williams sold 110 shares of Axon Enterprise, Inc. common stock on September 30, 2024, under a pre-arranged 10b5-1 trading plan.

Brittany Bagley, COO & CFO of Axon Enterprise, disposed of 12,365 shares of common stock on September 26, 2024, to cover tax liabilities from vesting restricted stock units.

Director Michael Garnreiter sold 1,000 shares of Axon Enterprise, Inc. at a price of $380.99 per share on September 16, 2024, according to a Form 4 filing with the SEC.

Brittany Bagley, COO & CFO of Axon Enterprise, sold 4,338 shares of common stock on September 12, 2024, at an average price of $378.948 per share.

Axon Enterprise's President, Joshua Isner, reported the sale of company stock on September 10, 2024, according to a Form 4 filing with the SEC.

Director Michael Garnreiter of Axon Enterprise, Inc. gifted 1,000 shares of common stock to a charitable donor-advised fund on September 10, 2024.

Brittany Bagley, COO & CFO of Axon Enterprise, disposed of 5,042 shares of common stock on September 7, 2024, to cover tax liabilities from vesting restricted stock units.

Jeffrey Kunins, CPO & CTO of Axon Enterprise, sold shares of common stock on September 9, 2024, under a pre-arranged Rule 10b5-1 trading plan, and also disposed of shares to cover tax liabilities from vesting restricted stock units.

Director Julie A. Cullivan sold 900 shares of Axon Enterprise, Inc. at a price of $353.53 per share on September 5, 2024, according to a Form 4 filing.

Axon Enterprise's CEO, Patrick W. Smith, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise's CEO, Patrick W. Smith, executed multiple sales of common stock between August 23 and August 27, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Jeri Williams sold 220 shares of Axon Enterprise, Inc. common stock at a price of $375.94 per share on August 22, 2024, under a pre-arranged 10b5-1 trading plan.

Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise, Inc. on August 21, 2024, at a price of $373.03 per share.

Director Michael Garnreiter sold 1,000 shares of Axon Enterprise, Inc. on August 16, 2024, at a price of $374.99 per share, according to a Form 4 filing with the SEC.

Axon Enterprise's COO & CFO, Brittany Bagley, sold shares of common stock on August 15, 2024, under a pre-arranged 10b5-1 trading plan.

Director Matthew R. McBrady reported selling shares of Axon Enterprise, Inc. in multiple transactions on August 9, 2024.

Brittany Bagley, COO & CFO of Axon Enterprise, disposed of shares to cover tax liabilities from vesting restricted stock units.

Joshua Isner, President of Axon Enterprise, sold shares of common stock on June 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Joshua Isner, President of Axon Enterprise, disposed of 1,077 shares of common stock on June 14, 2024, to cover tax liabilities from vesting restricted stock units.

Director Julie A. Cullivan sold 993 shares of Axon Enterprise, Inc. at a price of $281.72 per share on May 31, 2024, under a pre-arranged 10b5-1 trading plan.

Director Julie A. Cullivan sold 478 shares of Axon Enterprise, Inc. on May 28, 2024, at a price of $286.04 per share.

Caitlin Elizabeth Kalinowski, a director at Axon Enterprise, Inc., sold 2,000 shares of common stock at an average price of $290.1934 on May 20, 2024.

Director Adriane M. Brown reports acquisition of restricted stock units in Axon Enterprise, Inc.

Director Caitlin Elizabeth Kalinowski reports acquiring 657 shares of Axon Enterprise, Inc. common stock through time-vested restricted stock units.

Michael Garnreiter, a director of Axon Enterprise, Inc., reported the acquisition of restricted stock units on May 10, 2024.

Director Julie A. Cullivan reported the acquisition of restricted stock units in Axon Enterprise, Inc. on May 10, 2024.

Director Matthew McBrady acquired 657 shares of Axon Enterprise, Inc. common stock on May 10, 2024.